Veren (TSE:VRN – Free Report) had its price objective lowered by National Bankshares from C$13.50 to C$13.00 in a report issued on Friday, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.
Other equities analysts also recently issued research reports about the company. Raymond James decreased their price objective on Veren from C$13.00 to C$12.00 and set a “strong-buy” rating for the company in a report on Friday. BMO Capital Markets lowered their price target on shares of Veren from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research report on Friday. CIBC cut their price objective on shares of Veren from C$15.00 to C$13.00 in a report on Friday. Canaccord Genuity Group lowered their target price on shares of Veren from C$15.00 to C$14.00 in a report on Tuesday, October 22nd. Finally, Scotiabank reduced their price objective on Veren from C$12.00 to C$11.00 and set an “outperform” rating for the company in a research report on Friday. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Veren currently has a consensus rating of “Buy” and an average price target of C$11.89.
Get Our Latest Analysis on Veren
Veren Price Performance
Veren Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Sunday, December 15th will be paid a dividend of $0.115 per share. This represents a $0.46 dividend on an annualized basis and a yield of 6.43%. The ex-dividend date is Friday, December 13th.
Veren Company Profile
Veren Inc explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota.
Recommended Stories
- Five stocks we like better than Veren
- Options Trading – Understanding Strike Price
- Intel: Is Now the Time to Be Brave?
- Airline Stocks – Top Airline Stocks to Buy Now
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Why Invest in 5G? How to Invest in 5G Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Veren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veren and related companies with MarketBeat.com's FREE daily email newsletter.